about
Rapid, novel, specific, high-throughput assay for diagnosis of Loa loa infectionAn integrated in vitro imaging platform for characterizing filarial parasite behavior within a multicellular microenvironmentThe impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New GuineaEpidemiological and entomological evaluations after six years or more of mass drug administration for lymphatic filariasis elimination in NigeriaA multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasisLongitudinal monitoring of the development of antifilarial antibodies and acquisition of Wuchereria bancrofti in a highly endemic area of HaitiIdentification of Wb123 as an early and specific marker of Wuchereria bancrofti infectionDiagnosis of brugian filariasis by loop-mediated isothermal amplificationSecondary mapping of lymphatic filariasis in Haiti-definition of transmission foci in low-prevalence settingsImpact of six rounds of mass drug administration on Brugian filariasis and soil-transmitted helminth infections in eastern IndonesiaMolecular xenomonitoring using mosquitoes to map lymphatic filariasis after mass drug administration in American SamoaAnalysis of nematode motion using an improved light-scatter based systemA comprehensive assessment of lymphatic filariasis in Sri Lanka six years after cessation of mass drug administrationMapping of Bancroftian Filariasis in Cameroon: Prospects for EliminationProgrammatic Use of Molecular Xenomonitoring at the Level of Evaluation Units to Assess Persistence of Lymphatic Filariasis in Sri LankaLymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the EndgameUsing molecular data for epidemiological inference: assessing the prevalence of Trypanosoma brucei rhodesiense in tsetse in Serengeti, TanzaniaHigh prevalence of Wuchereria bancrofti infection as detected by immunochromatographic card testing in five districts of Orissa, India, previously considered to be non-endemicBayesian calibration of simulation models for supporting management of the elimination of the macroparasitic disease, Lymphatic Filariasis.An unusual presentation of filariasis: cytology solves the puzzle.Detection of Wuchereria bancrofti L3 larvae in mosquitoes: a reverse transcriptase PCR assay evaluating infection and infectivityApplication of a household-based molecular xenomonitoring strategy to evaluate the lymphatic filariasis elimination program in Tamil Nadu, India.First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards eliminationEpidemiological assessment of continuing transmission of lymphatic filariasis in Samoa.A case study of risk factors for lymphatic filariasis in the Republic of Congo.Molecular-based assay for simultaneous detection of four Plasmodium spp. and Wuchereria bancrofti infections.Evaluation of rapid blood sample collection in the detection of circulating filarial antigens for epidemiological survey by rWbSXP-1 capture assay.Inter and intra-specific diversity of parasites that cause lymphatic filariasisThe use of bivariate spatial modeling of questionnaire and parasitology data to predict the distribution of Schistosoma haematobium in Coastal Kenya.Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmissionDetection of Wuchereria bancrofti DNA in paired serum and urine samples using polymerase chain reaction-based systems.Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific.The application of biomedical engineering techniques to the diagnosis and management of tropical diseases: a review.A comparison of two tests for filarial antigenemia in areas in Sri Lanka and Indonesia with low-level persistence of lymphatic filariasis following mass drug administration.Lymphatic filariasis mapping by immunochromatographic test cards and baseline microfilaria survey prior to mass drug administration in Sierra Leone.Brugia Rapid™ antibody responses in communities of Indonesia in relation to the results of 'transmission assessment surveys' (TAS) for the lymphatic filariasis elimination programLoss of sensitivity of immunochromatographic test (ICT) for lymphatic filariasis diagnosis in low prevalence settings: consequence in the monitoring and evaluation proceduresEnhancing the Capacity of Policy-Makers to Develop Evidence-Informed Policy Brief on Infectious Diseases of Poverty in NigeriaModelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.
P2860
Q24646797-12AAD0BF-806F-45FA-B483-2B498AA04B8BQ27304737-0E958D42-77F8-4006-9BAB-C22364091555Q28474163-3CDAEEBA-910A-4EA2-B9FA-25A953DB1BEDQ28477441-B93F376E-6B9C-4DD0-9700-33A32A77587BQ28478938-D0DAE6B0-B44B-4D67-9221-7D709DD6F21BQ28484230-A285B0A5-878B-472D-8062-E482E1704490Q28484234-09520976-4653-46E0-8235-972EAC26EA4AQ28484345-920D6E75-890B-41B0-BF22-B3A1810797A8Q28484358-091C84EB-A020-4FE6-87A0-0F92698F2C21Q28536914-A016DFE2-D4F7-41DE-B0E7-79368BC66F8DQ28541935-ADD32A0F-2E76-417A-BD13-20664D4E546BQ28543545-5B15F9CF-32AD-4D45-83C2-B09DAC3929C9Q28544914-D54C5758-4CF4-453D-99E0-6B41D1E7017BQ28547792-02855A3D-8726-4A91-B136-9ECA21B126FCQ28552240-4F058C33-1656-4009-A82E-4EEB1030DBE7Q28553089-763506A4-887E-4F36-9C79-75C1A09F43F9Q30000933-23F2B012-7634-4373-A67D-F69B302C3458Q30395591-B816FF17-7EE8-4B7E-9304-B184F4648DCBQ30670492-F8C06056-63C7-4C39-8DCC-DA72E1DB99FBQ33353236-098F4D65-FA83-4ACB-99DB-2AAE816E0B47Q33532615-228310E4-F77F-4BDD-90CB-8CACE09DB01EQ33602799-D5F272F0-2D8B-4E78-948B-DA0E360D33C4Q33852823-71D2C078-9C4A-4847-BA26-D9A856EB17A9Q33873656-E25EA3FC-AD1D-4451-8BF3-81EEE9DBDD32Q33874155-EAE09694-607E-42B6-883A-D4DFB0909D71Q33880608-4C06D5CA-47F6-4E67-B678-7E3817EEC88BQ33904395-DA7AFF4E-45B3-4CD4-B0FC-0022B7E1C9B5Q34497425-9777037F-F311-4FAA-BAED-B11DECE1E02EQ34566637-36E8DE39-3CAD-4514-95C1-A266E9247EC6Q34839765-876819F0-C270-4566-A11E-4B9822693327Q35076420-4F471EF1-8D0D-4C73-99AC-854138468805Q35234005-C268090F-01E6-49FF-BBFD-FC8C3A47B667Q35617736-E2388D97-D052-4E5C-AB92-FC1613FA1621Q35689798-9C454893-531C-476F-9103-73067FF208FAQ35712047-4BDF0722-9DC1-4C2C-B16A-8927ABA946E8Q35795540-57F96BF5-948B-4644-BFE0-B5808D6A6186Q35877618-67B8112E-DE8E-4613-BD3B-40FC16F76CE8Q36016770-CDB99D94-C5B8-48D1-88D1-EA972773EEE5Q36201275-D8D5AF17-EDA1-4141-804F-8D0627ADF6D6Q36204671-6AB33B28-D5E5-430E-96E4-775670005C75
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Diagnostic tools for filariasis elimination programs.
@ast
Diagnostic tools for filariasis elimination programs.
@en
type
label
Diagnostic tools for filariasis elimination programs.
@ast
Diagnostic tools for filariasis elimination programs.
@en
prefLabel
Diagnostic tools for filariasis elimination programs.
@ast
Diagnostic tools for filariasis elimination programs.
@en
P356
P1476
Diagnostic tools for filariasis elimination programs
@en
P2093
Gary J Weil
P356
10.1016/J.PT.2006.12.001
P50
P577
2006-12-14T00:00:00Z